University of Cambridge
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
T-Therapeutics
13 Nov 2025
T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
T-Therapeutics develops next-generation T cell receptor therapies designed to target cancer and autoimmune disease, advancing bispecific molecules that selectively remove disease-driving immune cells while preserving healthy function.
NoBACZ
30 Sept 2025
NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses
NoBACZ Healthcare develops antibiotic-free liquid bandage technology for livestock and horses, creating protective wound coatings that reduce infection risk in agricultural environments.
Robin AI
14 Nov 2024
Robin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal Ventures
Robin AI develops legal AI software for large enterprises that analyses, summarises and extracts insights from complex contracts and documents, supporting due diligence, compliance and incident response at scale.
University of Cambridge
More venture news
- 5 Aug 2026
Wordsmith AIWordsmith AI raises a £10m Series B extension led by Intact Private Capital for its in-house legal AI platform
ExtensionLegal - 10 Aug 2026
EdgifyEdgify raises a £6.7m Series A+ round from Rank Ventures and Mangrove Capital Partners for edge AI that prevents in-store retail loss
ExtensionCommerce - 23 Jul 2026
YopeYope raises a £9.2m Pre-Series A round led by Northzone to build private social platform for close friends
ExtensionConsumer
